Mydecine Innovations Group Inc. announced the appointment of Dr. Victoria Hale to the company's Board of Directors. Dr. Hale is a pharmaceutical scientist and executive, as well as a global health social entrepreneur. She currently serves as Chair of the Board of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0128 USD | -33.26% | +1.27% | -14.36% |
May. 01 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
Feb. 23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
-14.36% | 788K | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Appoints Victoria Hale as Newest Independent Board Member